MedPath
NMPA Approval

Roxatidine Acetate Hydrochloride For Injection

国药准字H20243855

May 28, 2024

Drug Information

注射用盐酸罗沙替丁醋酸酯

注射剂

75mg

化学药品

May 28, 2024

Company Information

Applicant Company

武汉经济技术开发区海特科技园

Manufacturing Company

湖北省武汉经济技术开发区海特科技园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸罗沙替丁醋酸酯 - NMPA 批准文号 | MedPath